Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Panacea Biotec Ltd.
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-1.37-0.19-5.43175.98-24.11
Diluted EPS (Rs.)-1.37-0.19-5.43175.98-24.11
Cash EPS (Rs.)4.265.750.87183.11-16.68
Book Value[Excl.RevalReserv]/Share (Rs.)136.18133.94133.63138.09-41.36
Book Value[Incl.RevalReserv]/Share (Rs.)136.18133.94133.63138.09-41.36
Revenue From Operations / Share (Rs.)91.2191.2975.09107.96102.01
PBDIT / Share (Rs.)-0.850.93-7.56-0.4714.14
PBIT / Share (Rs.)-6.54-5.06-13.95-7.606.70
PBT / Share (Rs.)-1.300.242.09236.54-23.56
Net Profit / Share (Rs.)-1.42-0.24-5.51175.98-24.12
NP After MI And SOA / Share (Rs.)-1.37-0.19-5.43175.98-24.11
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)-0.931.02-10.06-0.4313.86
PBIT Margin (%)-7.16-5.53-18.57-7.046.56
PBT Margin (%)-1.420.262.78219.10-23.09
Net Profit Margin (%)-1.55-0.26-7.33163.01-23.64
NP After MI And SOA Margin (%)-1.49-0.20-7.22163.01-23.63
Return on Networth / Equity (%)-1.00-0.14-4.04126.990.00
Return on Capital Employeed (%)-4.34-3.32-9.09-4.755.44
Return On Assets (%)-0.64-0.09-2.6160.47-12.52
Long Term Debt / Equity (X)0.020.010.010.03-2.92
Total Debt / Equity (X)0.020.010.010.03-2.92
Asset Turnover Ratio (%)0.440.440.300.240.31
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.491.571.711.301.20
Quick Ratio (X)0.900.991.101.030.79
Inventory Turnover Ratio (X)1.091.111.021.140.58
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)-1.351.60-10.43-0.010.46
Interest Coverage Ratio (Post Tax) (%)-10.52-9.48-29.74-2.310.21
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)2612.25620.65454.38355.931682.86
EV / Net Operating Revenue (X)4.671.110.980.532.69
EV / EBITDA (X)-497.57108.22-9.81-122.8619.43
MarketCap / Net Operating Revenue (X)4.831.331.441.371.74
Price / BV (X)3.240.900.801.07-4.34
Price / Net Operating Revenue (X)4.831.331.441.371.74
EarningsYield0.000.00-0.051.19-0.13
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-1.37
Diluted EPS (Rs.)-1.37
Cash EPS (Rs.)4.26
Book Value[Excl.RevalReserv]/Share (Rs.)136.18
Book Value[Incl.RevalReserv]/Share (Rs.)136.18
Revenue From Operations / Share (Rs.)91.21
PBDIT / Share (Rs.)-0.85
PBIT / Share (Rs.)-6.54
PBT / Share (Rs.)-1.30
Net Profit / Share (Rs.)-1.42
NP After MI And SOA / Share (Rs.)-1.37
PROFITABILITY RATIOS 
PBDIT Margin (%)-0.93
PBIT Margin (%)-7.16
PBT Margin (%)-1.42
Net Profit Margin (%)-1.55
NP After MI And SOA Margin (%)-1.49
Return on Networth / Equity (%)-1.00
Return on Capital Employeed (%)-4.34
Return On Assets (%)-0.64
Long Term Debt / Equity (X)0.02
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)0.44
LIQUIDITY RATIOS 
Current Ratio (X)1.49
Quick Ratio (X)0.90
Inventory Turnover Ratio (X)1.09
COVERAGE RATIOS 
Interest Coverage Ratio (%)-1.35
Interest Coverage Ratio (Post Tax) (%)-10.52
VALUATION RATIOS 
Enterprise Value (Cr.)2612.25
EV / Net Operating Revenue (X)4.67
EV / EBITDA (X)-497.57
MarketCap / Net Operating Revenue (X)4.83
Price / BV (X)3.24
Price / Net Operating Revenue (X)4.83
EarningsYield0.00